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Abstract A method of determination for solasodine glycosides 
by using thin-layer chromatography (TLC) immunostaining was 
investigated. Solasodine glycosides separated by silica gel TLC 
were transferred to a polyvinylidene difluoride membrane. The 
membrane was treated with sodium periodate solution followed 
by bovine serum albumin (BSA), resulting in a solasodine 
glycoside-BSA conjugate. Conjugation was confirmed by matrix-
assisted laser desorption/ionization mass spectrometry. Individ-
ual spots were stained by monoclonal antibody against solamar-
gine. Immunostaining of solasodine glycosides was more sensitive 
compared to other stainings. The newly established immuno-
staining method can be extended to analysis of the distribution of 
solasodine glycoside in the plant body. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
In the recent rapid development of the molecular bioscien-
ces and their biotechnological applications, immunoassay sys-
tems using MAbs against drugs and biologically active com-
pounds of low molecular weight have become important tools 
[1] for studies on receptor binding analysis, enzyme assays and 
quantitative and/or qualitative analytical techniques in ani-
mals or plants, owing to their specific affinity. In previous 
papers, we reported methods for the direct determination 
for antigen conjugates by M A L D I mass spectrometry [2-4], 
and the production of MAbs and enzyme immunoassay for 
solamargine [5], forskolin [6,7], opium alkaloids [8] and mar-
ihuana compounds (cannabinoids) [9]. 
In continuation of studies on the breeding of medicinal 
plants, we have already reported the higher yielding strain 
of cannabidiolic acid which is designated a non-toxic mari-
huana strain [10], and clonal and homogeneous medicinal 
strains [11-13], and virus-free plants [14] using plant biotech-
nology. 
*Corresponding author. Fax: (81) (92) 641-8154. 
Abbreviations: TLC, thin-layer chromatography; PVDF, polyvinyl-
idene difluoride; MALDI, matrix-assisted laser desorption/ionization; 
TOF, time-of-flight; BSA, bovine serum albumin; HSA, human serum 
albumin; TPBS, phosphate buffer solution containing 0.05% Tween 
20; GPBS, phosphate buffer solution containing 0.2% gelatin; ELISA, 
enzyme-linked immunosorbent assay; MAb, monoclonal antibody; 
ABTS, 2,2'-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) diammo-
nium salt. 
The natural resources of adrenocortical hormones and sex 
hormones, which are mainly obtained from diosgenin, are 
becoming rare. The most important feature of solasodine is 
that it can be converted to dehydropregnenolone. Solasodine 
is found with a series of sugar residues attached to the oxygen 
at the C-3 position. By far the most common forms are the 
triglycosides, solamargine being predominant [15]. Therefore, 
the steroidal alkaloid glycosides of the solasodine type like 
solamargine have become important as a starting material 
for the production of steroidal hormones in the pharmaceut-
ical and medicinal areas. Rapid, simple, highly sensitive and 
reproducible assay systems are required for a large number of 
plants, and a limited small amount of samples, in order to 
select the strain of higher yielding steroidal alkaloid glyco-
sides. 
We here wish to present a simple determination method for 
solasodine glycosides by using T L C immunostaining. 
2. Materials and methods 
2.1. Chemicals and immunochemicals 
BSA and HSA were provided by Pierce (Rockford, IL, USA). Per-
oxidase-labeled anti-mouse IgG was provided by Organon Teknika 
Cappel Pruducts (West Chester, PA, USA). PVDF membranes (Im-
mobilon-N) were purchased from Millipore Corp. (Bedford, MA, 
USA). Glass microfiber filter sheets (GF/A) were purchased from 
Whatman International Ltd. (Maidstone, UK). All other chemicals 
were standard commercial products of analytical grade. 
Fruit of S. khasianum was obtained from the herbal garden of the 
Faculty of Pharmaceutical Sciences, Kyushu University, Japan. Sol-
amargine and solasonine were isolated from fresh fruits of S. khasia-
num as previously described [15]. Solasodine was obtained from sol-
amargine by acid hydrolysis as described in [15]. Solamargine (1 mg) 
was dissolved in MeOFf containing 1 M HC1 (1 ml). The mixture was 
heated at 70°C for 10, 20, 30, 60 and 90 min, respectively. Individual 
hydrolysates were evaporated in vacuo and applied to TLC. Spots 
developed on TLC were determined using H2SO4 and Dragendorff 
reagent. 
An immunogen, solamargine-BSA conjugate, was synthesized from 
solamargine by NaIC>4 treatment followed by conjugation with BSA 
as reported previously [16] with modifications. Immunization and hy-
bridization were carried out as reported [5] from this laboratory. A 
cultured medium (50 ml) containing the IgG (SMG-BD9) [5] was 
purified by using a Chromatop Protein A column [17] (0.46X25 cm, 
NGK Insulators, Ltd., Nagoya, Japan), dialyzed 5 times against H2O, 
and finally lyophilized to give IgG (0.53 mg). 
2.2. TLC 
Solasodine glycosides were applied to a TLC plate and developed 
with chloroform/methanol/ammonia solution (7:2.5:1). The developed 
TLC plate was dried and then sprayed with a blotting solution mix-
ture of isopropanol/methanol/water (5:20:40, by vol.). It was placed 
on a stainless-steel plate, then covered with a PVDF membrane sheet. 
After covering with a glass microfiber filter sheet, the whole was 
pressed evenly for 45 s with a 130°C iron as previously described 
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taining BSA (1%) was added, and stirred at room temperature for 3 h. 
The PVDF membrane was washed twice with TPBS for 5 min, and 
then washed with water. The PVDF membrane was immersed in anti-
solamargine MAb, stirred at room temperature for 1 h. After washing 
the PVDF membrane twice with TPBS and water, a 1000-fold dilution 
of peroxidase-labeled goat anti-mouse IgG in GPBS was added and 
stirred at room temperature for 1 h. The PVDF membrane was 
washed twice with TPBS and water, then exposed to 1 mg/ml 4-
chloro-l-naphthol-0.03% H2O2 in PBS solution which was freshly 
prepared before use for 10 min at room temperature, and the reaction 
was stopped by washing with water. The immunostained PVDF mem-
brane was allowed to dry. 
2.4. Extraction of solasodine glycoside-BSA conjugate from PVDF 
membrane 
The band of solasodine glycoside-BSA conjugate on PVDF was 
extracted with 0.1 M acetate buffer (pH 4) under stirring at 4°C over-
night. The solution was dialyzed against H 2 0 . 
Fig. 1. TLC immunostainings of solamargine and solasonine. Sola-
margine (upper spot) and solasonine (bottom spot) were developed 
by CHCl3-MeOH-NH4OH solvent system on silica gel TLC plate. 
Lanes 1-5 show the concentrations of both alkaloids, 0.8, 1.6, 8, 40 
and 200 ng, respectively. After transfer to PVDF membrane, the 
membrane was treated with NaIC>4 and stained by MAb. 
[18] with modifications. The PVDF membrane was separated from the 
plate and dried. 
2.3. Immunostaining of solasodine glycosides on PVDF membrane 
The blotted PVDF membrane was dipped in water containing 
NaI04 (10 mg/ml) under stirring at room temperature for 1 h. After 
washing with water, 50 mM carbonate buffer solution (pH 9.6) con-
2.5. Analysis by MALDI mass spectrometry 
A small amount (1-10 pM) of the solasodine glycoside-BSA con-
jugate extracted from the PVDF membrane was mixed with a 103-fold 
molar excess of sinapinic acid in an aqueous solution containing 10% 
trifluoroacetic acid. The mixture was placed inside a JMS-LDI 1700 
TOF mass monitor and irradiated with a N2 laser (337 nm, 3 ns 
pulse). The ions formed by each pulse were accelerated by a 30 kV 
potential into a 1.7 m evacuated tube and detected using a Micro-
channel Plate Detector with an IBM PC compatible computer as 
reported in [2-4]. 
3. Results and discussion 
After the solasodine glycosides had been transferred to the 
PVDF membrane sheet from the TLC plate by heating (see 
Fig. 3. Products of HCl hydrolysis of solamargine. a-c depict TLC immunostaining, staining with sulfuric acid and staining with Dragendorff 
reagent, respectively. Solamargine was hydrolyzed using 1 M HCl for 10, 20, 30, 60 and 90 min, respectively. Spots \-4 were identified with 
solasodine, 3-0-|3-D-glucopyranosyl solasodine, L-rhamnosyl-(l->4)-0-3-p-D-glucopyranosyl solasodine and L-rhamnosyl-(l->2)-3-(3-0-D-gluco-
pyranosyl solasodine, respectively. 
Fig. 4. The sliced fruit of Solanum khasianum and its immunostaining. The PVDF membrane covered the surface of the sliced fruit, and was 
stained in the same manner via TLC immunostaining as indicated in Fig. 1. 
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Fig. 2. MALDI mass spectrometry of solamargine-BSA conjugate. 
Section 2) as previously reported [18] with modifications, the 
PVDF membrane was treated with NaI04 solution followed 
by conjugation with BSA since solasodine glycosides on 
PVDF membranes are washed out by buffer solution or water 
without the formation of a conjugate with the carrier protein. 
The PVDF membrane was immersed in anti-solamargine 
MAb, and then peroxidase-labeled secondary MAb. on addi-
tion of substrate and H2O2, clear blue spots appeared as 
shown in Fig. 1. Fig. 1 shows the immunostaining of solamar-
gine and solasonine. Lanes 1-5 demonstrate the concentra-
tions of both alkaloids, 0.8, 1.6, 8, 40 and 200 ng, respectively. 
Different sensitivities between solamargine and solasonine 
were observed in individual concentrations, and the sensitivity 
of solasonine was somewhat higher than that of solamargine. 
The detection limit was 1.6 ng solasonine. 
In order to confirm the preparation of solamargine-BSA 
conjugate on the PVDF membrane, the band corresponding 
to the solamargine-BSA conjugate was assessed by MALDI 
mass spectrometry (Fig. 2). A broad peak 2 [M+H]+ of sol-
amargine-BSA conjugate appeared at around m/z 69043 in 
MALDI mass spectrometry demonstrating that at least 1-2 
molecules and up to 15 molecules of solamargine had com-
bined. Therefore, it becomes clear that the sugar moiety which 
was conjugated with BSA is necessary in this staining system. 
To expand this newly established immunostaining method, 
solamargine was hydrolyzed by 1 M HC1 for 10, 20, 30 and 60 
min, respectively. Individual hydrolysates were applied to 
three TLC plates and then developed with a CHCVMeOH/ 
NH4OH solvent system. Two plates were sprayed and colored 
with H2S04 and Dragendorff reagents, respectively. One plate 
was transferred to a PVDF membrane. Fig. 3 shows the im-
munostaining (a), and stainings by H2SO4 (b) and Dragen-
dorff reagent (c). On comparing the staining sensitivities of the 
three methods, the immunostaining was found to be the most 
extensive followed by H2SO4 and then Dragendorff reagent. It 
is easily suggested that product 1 may be an aglycone of 
solamargine, solasodine and that products 2-4 might be sol-
asodine mono- and diglycosides. Therefore, products \-A were 
identified as solasodine, 3-O-p-D-glucopyranosyl-solasodine, 
0-a-L-rhamnosyl-(l ->4)-3-0-P-D-glucopyranosyl-solasodine 
and 0-oc-L-rhamnosyl-(l ->2)-3-0-P-D-glucopyranosyl-solaso-
Table 1 
Cross-reactivities of monoclonal antibody (SMG-BD9) against ster-
oidal compounds 
Compound Cross-reactivities (%) 
Solamargine 100 
Solasonine 92.1 
3-O-P-D-Glucopyranosyl-solasodine 11 
0-a-L-Rhamnosyl-(l -> 4)-3-0-P-D- 17 
glucopranosyl-solasodine 
0-a-L-Rhamnosyl-(l ->2)-3-0-P-D- 36 
glucopranosyl-solasodine 
Tomatine 2.1 
Tomatigine 0.3 
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dine, respectively, by direct comparison with authentic sam-
ples. As compared with the staining between immunostaining 
(a) and sulfuric acid (b), solasodine was not detected by im-
munostaining despite having 44% cross-reactivity [5] resulting 
in good agreement with previous evidence. Table 1 lists the 
cross-reactions of individual hydrolyzed products. The cross-
reactivities of three hydrolyzed products were 11, 17 and 36%, 
together with solamargine (100%) and solasonine (92.1%). 
The cross-reactions of tomatidine and tomatine which are 
structurally related to solasodine and its glycoside were insig-
nificant in tomatine (2.1%) and undetectable in tomatidine 
(0.3%)). Other steroidal compounds did not cross-react with 
anti-solamargine antibodies (data not shown). 
Fig. 4 depicts immunostaining and the sliced fruit of S. 
khasianum. It became evident that seeds and pericarp con-
tained a higher concentration of solasodine glycosides as com-
pared to other tissues. To confirm this result, we analyzed 
these tissues individually by ELISA. The seeds contained 
18 ± 2 (ig/ml of solasodine glycosides, the inner and outer 
pericarp having 0.43 and 0.12 u\g/ml, respectively, thus show-
ing good agreement with immunostaining. 
This is the first report in which immunostaining for solaso-
dine glycosides and its application have been described. This 
assay method can be routinely used for surveying natural 
resources of solasodine glycosides as a simple and rapid anal-
ysis. Moreover, this methodology may be available for the 
assay of in vitro plantlets of 5. khasianum, therefore making 
it possible to study a large number of cultured plantlets, and a 
limited small amount of sample in vitro for the breeding of 
Solarium species containing higher amounts of steroidal alka-
loids for the continuation of our medicinal plant breeding. 
Furthermore, this system may be available for the analysis 
of animal plasma samples of glycoside or glucuronide, and 
not be limited to solasodine glycosides and/or distributions 
in organs or tissues since very low concentrations are ex-
pected. Although it is difficult to detect a low molecular 
weight compound by western blotting, the approach described 
here will be particularly attractive in a wide variety of com-
parable situations as indicated in the distribution of solaso-
dine glycosides in the fruit of S. khasianum (Fig. 4). In ex-
tending studies of this result, naturally occurring 
pharmacologically active glycosides for the central nervous 
system like ginsenosides Rbi [19] and crocin [20] have been 
investigated. These results will be communicated elsewhere. 
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